BioMarin Pharmaceutical | 販売および管理費



Selling And Administration Expenses 変化する 日付
Acadia Pharmaceuticals USD 126.37M 3.71M 2025-03
Agios Pharmaceuticals USD 41.53M 10.17M 2025-03
Alnylam Pharmaceuticals USD 239.95M 55.39M 2025-03
Amgen USD 1.69B 191M 2025-03
Bayer EUR 3.71B 628M 2025-03
Biogen USD 572.5M 104.8M 2025-03
BioMarin Pharmaceutical USD 206.12M 50.65M 2025-03
Gilead Sciences USD 1.26B 603M 2025-03
Incyte USD 325.69M 1.02M 2025-03
Insmed USD 147.54M 5.03M 2025-03
Ionis Pharmaceuticals USD 76M 12.08M 2025-03
Moderna USD 212M 139M 2025-03
Neurocrine Biosciences USD 287.8M 53.5M 2024-12
PTC Therapeutics USD 161.92M 77.24M 2025-03
Regeneron Pharmaceuticals USD 633M 159.2M 2025-03
Roche Holding CHF 3.61B 381M 2024-12
Sanofi EUR 1.24B 1.44B 2024-12
Sarepta Therapeutics USD 133.63M 30.24M 2025-03
Ultragenyx Pharmaceutical USD 87.8M 5.3M 2025-03
United Therapeutics USD 170.1M 7.6M 2025-03
Vertex Pharmaceuticals USD 377.6M 5.8M 2024-12



BioMarin Pharmaceutical 販売および管理費 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - May 2025.